Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 20451621)

1.

Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge.

Stokes PR, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, Nutt DJ, Mehta MA.

Neuroimage. 2010 Oct 1;52(4):1521-7. doi: 10.1016/j.neuroimage.2010.04.274. Epub 2010 May 6.

PMID:
20451621
2.

Can recreational doses of THC produce significant dopamine release in the human striatum?

Stokes PR, Mehta MA, Curran HV, Breen G, Grasby PM.

Neuroimage. 2009 Oct 15;48(1):186-90. doi: 10.1016/j.neuroimage.2009.06.029. Epub 2009 Jun 17.

PMID:
19539765
3.

Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.

Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, Hagelberg N, Oikonen V, Hietala J.

Nucl Med Commun. 2003 Dec;24(12):1207-14.

PMID:
14627846
4.

Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride.

Ikoma Y, Watabe H, Hayashi T, Miyake Y, Teramoto N, Minato K, Iida H.

Neuroimage. 2009 Oct 1;47(4):1639-48. doi: 10.1016/j.neuroimage.2009.05.099. Epub 2009 Jun 9.

PMID:
19520172
5.

Error analysis for PET measurement of dopamine D2 receptor occupancy by antipsychotics with [11C]raclopride and [11C]FLB 457.

Ikoma Y, Ito H, Arakawa R, Okumura M, Seki C, Shidahara M, Takahashi H, Kimura Y, Kanno I, Suhara T.

Neuroimage. 2008 Oct 1;42(4):1285-94. doi: 10.1016/j.neuroimage.2008.05.056. Epub 2008 Jun 10.

PMID:
18585466
6.

Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.

Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.

Neuroimage. 2013 Nov 15;82:252-9. doi: 10.1016/j.neuroimage.2013.05.091. Epub 2013 May 28.

PMID:
23727314
7.

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.

Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M.

Synapse. 2004 Jun 1;52(3):188-208.

PMID:
15065219
8.

Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.

Hirvonen J, Karlsson H, Kajander J, Markkula J, Rasi-Hakala H, Någren K, Salminen JK, Hietala J.

Psychopharmacology (Berl). 2008 May;197(4):581-90. doi: 10.1007/s00213-008-1088-9. Epub 2008 Feb 5.

PMID:
18251011
9.

Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.

Alakurtti K, Aalto S, Johansson JJ, Någren K, Tuokkola T, Oikonen V, Laine M, Rinne JO.

J Cereb Blood Flow Metab. 2011 Jan;31(1):155-65. doi: 10.1038/jcbfm.2010.64. Epub 2010 May 5.

10.

Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.

Narendran R, Jedema HP, Lopresti BJ, Mason NS, Gurnsey K, Ruszkiewicz J, Chen CM, Deuitch L, Frankle WG, Bradberry CW.

Mol Psychiatry. 2014 Mar;19(3):302-10. doi: 10.1038/mp.2013.9. Epub 2013 Feb 26. Erratum in: Mol Psychiatry. 2014 Mar;19(3):399.

11.

Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride.

Kodaka F, Ito H, Kimura Y, Fujie S, Takano H, Fujiwara H, Sasaki T, Nakayama K, Halldin C, Farde L, Suhara T.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):574-9. doi: 10.1007/s00259-012-2312-8. Epub 2012 Dec 14.

PMID:
23238524
12.

Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.

Penttilä J, Kajander J, Aalto S, Hirvonen J, Någren K, Ilonen T, Syvälahti E, Hietala J.

Int J Neuropsychopharmacol. 2004 Dec;7(4):431-9. Epub 2004 Jul 26.

PMID:
15315717
13.

Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.

Catafau AM, Suarez M, Bullich S, Llop J, Nucci G, Gunn RN, Brittain C, Laruelle M; Barcelona Clinical Imaging in Psychiatry Group.

Neuroimage. 2009 Jun;46(2):447-58. doi: 10.1016/j.neuroimage.2009.02.005. Epub 2009 Feb 20.

PMID:
19233294
14.

Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers.

Ribeiro MJ, Ricard M, Bourgeois S, Lièvre MA, Bottlaender M, Gervais P, Dollé F, Syrota A.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):952-8. Epub 2005 Apr 20.

PMID:
15841376
15.

Design and implementation of an automated partial volume correction in PET: application to dopamine receptor quantification in the normal human striatum.

Rousset OG, Collins DL, Rahmim A, Wong DF.

J Nucl Med. 2008 Jul;49(7):1097-106. doi: 10.2967/jnumed.107.048330. Epub 2008 Jun 13.

16.

Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.

Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P, Koudsie A, Le Bars D, Benabid AL, Broussolle E.

J Neurol. 2003 Oct;250(10):1219-23.

PMID:
14586606
17.

Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.

Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P.

Brain. 2003 May;126(Pt 5):1127-35.

18.

Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.

Egerton A, Ahmad R, Hirani E, Grasby PM.

Psychopharmacology (Berl). 2008 Nov;200(4):487-96. doi: 10.1007/s00213-008-1226-4. Epub 2008 Jul 3.

PMID:
18597077
19.

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.

Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N.

Am J Psychiatry. 1997 Jan;154(1):50-5.

PMID:
8988958
20.

Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men.

Leyton M, Dagher A, Boileau I, Casey K, Baker GB, Diksic M, Gunn R, Young SN, Benkelfat C.

Neuropsychopharmacology. 2004 Feb;29(2):427-32.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk